KCT0002471
Completed
未知
A randomized, open-label, single dose, crossover study to compare the pharmacokinetic characteristics of the co-administration of metformin SR and rosuvastatin and JLP-1310 in healthy male volunteers
Jeil Pharmaceutical0 sites40 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Jeil Pharmaceutical
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Healthy male volunteer, age is over 19 years Body weight is over 50kg, The result of Body Mass Index(BMI) is not less than 18\.0 kg/m2 , no more than 29\.0 kg/m2
- •2\) Subject who has the ability to comprehend the study objectives, contents and the property of the study drug before participating in the trial
- •3\) Subject who has the ability and willingness to participate the whole period of trial
Exclusion Criteria
- •1\)Presence of medical history or a concurrent disease that may interfere with treatment and safety assessment or completion of this clinical study, including clinically significant disorders in kidney, liver, cardiovascular system, respiratory system, endocrine system, or neuropsychiatric system.
- •2\)Subjects who are allergic to investigational drug.
- •3\)Subjects who have a medical history which can affect the clinical trial.
- •4\)Systolic BP \= 150mmHg, BP \=100mmHg or Diastolic BP\= 95mmHg, BP \= 55 mmHg
- •5\)AST or ALT \> X 2 UNL
- •6\)History of drug abuse or positive drug screening.
- •7\)Participation in other drug studies within 90 days prior to the drug administration.
- •8\)Whole blood donation within 60 days, blood component donation within 30 days or who got transfusion within 30days.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The aim of this study is to compare and evaluate the pharmacokinetic properties and safety of oral administration of KD4002Endocrine, nutritional and metabolic diseasesKCT0007759Kyung Dong Pharmaceutical32
Completed
Not Applicable
The effect of food on the pharmacokinetics of JLP-1310Endocrine, nutritional and metabolic diseaseKCT0002625Jeil Pharmaceutical16
Completed
Not Applicable
A randomized, open-label, single dose, crossover study to investigate the effect of food on the pharmacokinetics of JLP-1310 in healthy male volunteersEndocrine, nutritional and metabolic diseaseKCT0001497Chonbuk National University Hospital16
Completed
Not Applicable
Study to Evaluate the pharmacokinetic characteristics of the JLP-1310(1000/10mg)Endocrine, nutritional and metabolic diseaseKCT0003623Inha University Hospital40
Completed
Not Applicable
The aim of this study is to compare and evaluate the pharmacokinetic properties and safety of oral administration of KD4002Endocrine, nutritional and metabolic diseasesKCT0007757Kyung Dong Pharmaceutical40